Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.
- 1 May 1988
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 85 (9) , 3090-3094
- https://doi.org/10.1073/pnas.85.9.3090
Abstract
X chromosome-linked severe combined immunodeficiency (XSCID) is characterized by markedly reduced numbers of T cells, the absence of proliferative responses to mitogens, and hypogammaglobulinemia but normal or elevated numbers of B cells. To determine if the failure of the B cells to produce immunoglobulin might be due to expression of the XSCID gene defect in B-lineage cells as well as T cells, we analyzed patterns of X chromosome inactivation in B cells from nine obligate carriers of this disorder. A series of somatic cell hybrids that selectively retained the active X chromosome was produced from Epstein-Barr virus-stimulated B cells from each woman. To distinguish between the two X chromosomes, the hybrids from each woman were analyzed using an X-linked restriction fragment length polymorphisms for which the woman in question was heterozygous. In all obligate carriers of XSCID, the B-cell hybrids demonstrated preferential use of a single X chromosome, the nonmutant X, as the active X. To determine if the small number of B-cell hybrids that contained the mutant X were derived from an immature subset of B cells, lymphocytes from three carriers were separated into surface IgM positive and surface IgM negative B cells prior to exposure to Epstein-Barr virus and production of B-cell hybrids. The results demonstrated normal random X chromosome inactivation in B-cell hybrids derived from the less mature surface IgM positive B cells. In contrast, the pattern of X chromosome inactivation in the surface IgM negative B cells, which had undergone further replication and differentiation, was significantly nonrandom in all three experiments [logarithm of odds (lod) score > 3.0]. These results suggest that the XSCID gene product has a direct effect on B cells as well as T cells and is required during B-cell maturation.This publication has 39 references indexed in Scilit:
- Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation.Journal of Clinical Investigation, 1987
- Heterogeneity of lymphocyte subpopulations in severe combined immunodeficiency. Evidence against a stem cell defect.Journal of Clinical Investigation, 1976
- SEVERE COMBINED IMMUNODEFICIENCY WITH B-LYMPHOCYTES - INVITRO CORRECTION OF DEFECTIVE IMMUNOGLOBULIN PRODUCTION BY ADDITION OF NORMAL T-LYMPHOCYTES1976
- IMMUNOLOGICAL OBSERVATIONS ON PATENTS WITH LESCH-NYHAN SYNDROME, AND ON THE ROLE OF DE-NOVO PURINE SYNTHESIS IN LYMPHOCYTE TRANSFORMATIONThe Lancet, 1975
- X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells.The Journal of Experimental Medicine, 1975
- Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosisClinical Immunology and Immunopathology, 1975
- Studies on the Thymic Dependence of the Immunoglobulin Classes of the MouseExperimental Biology and Medicine, 1975
- The Origin and Development of Human Tumors Studied with Cell MarkersNew England Journal of Medicine, 1974
- SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTESThe Journal of Experimental Medicine, 1973
- Hemizygous Expression of Glucose-6-Phosphate Dehydrogenase in Erythrocytes of Heterozygotes for the Lesch-Nyhan SyndromeProceedings of the National Academy of Sciences, 1970